TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Prevalence of elevated albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Frequency of Biceps Femoris Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of Semitendinosus Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Stiffness of Biceps Femoris Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Stiffness of Semitendinosus Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrement of Biceps Femoris Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Susceptibility of sensitization at the peripheral and central levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSMA PET response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Semmes-Weinstein monofilament testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in two-point discrimination test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in temperature perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Radiographic Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Muscle strength and functional mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of somatic mutation accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Specificity of Sonotubometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Sonotubometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pharmacokinetics of bupivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of telemedicine diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Speech assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Five-Point Telangiectasia Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Vulvar and Vaginal Health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: time of success for fiberoptic endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change scores of Geriatric Depression Scale (GDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Days on ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Concentrations of Anti-gE Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Progression of sternal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-mental state pediatric examination (MMSPE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient and Caregiver Unmet Needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of Situation Awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: occurrence of osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: monocytic HLA-DR (mHLA-DR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in Composite Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy of ds-MCE in identifying esophagogastric varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Kidney microstructure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change of Purdue Pegboard Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6 Minutes walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMG surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard visual analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in glycemic control (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Agreement in intervertebral translation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Agreement in intervertebral rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Agreement in translation-per-degree-of-rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Interobserver agreement regarding clinical condition at first evaluation point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interobserver agreement regarding clinical condition at second evaluation point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of frameworks developed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical improvement of oral lichen planus lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of drug/dose selection or modification
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lung cancer screening adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence and severity of treatment-emergent AEs (TEAEs) and serious TEAEs (STEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with abnormal clinical significant measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with clinical significant elevation in NPRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of ZG0895.HCl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular DCNVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck's Depression Inventory - II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incremental shuttle walking test (ISWT) distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in telomer analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of wheelchair skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieved skeletal corrections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal adductor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adductor fatigue strength test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Area under curve (AUC) of the weight loss prediction model after 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under curve (AUC) of the T2DM remission prediction model after 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum observed concentration (Cmax) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Cmax (peak time, Tmax) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal Phase Elimination Half-life (t1/2) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) from Time 0 to the Time of the Last Measurable Concentration (AUC0-t) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expressive vocabulary at 18 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Child Anxiety Scale-State Scale (CAS-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement of the degree of proptosis after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative and positive predictive value (NPV and PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False positive
Endpoint domain: Adverse events/effects
Primary endpoint: False negative
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose (MTD) as measured by Dose-Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative Airway Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of lumbar pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Functional scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sciatica Bothersomeness Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence rate of organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of SON-080
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants achieving pathological complete response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy/vigor
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of Participants Experiencing Study Drug-Related Grade 3 or Higher Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Study Drug-Related Immune-Related Adverse Events (IRAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Massachusetts General Hospital- Hair Pulling Scale (MGH-HPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usage, Satisfaction, Ease of use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma level of NAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inattention as measured by ADHD Rating Scale-5
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perception of Risk of Heart Disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Systemic Coronary Risk Estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient Health Questionnaire-4
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prosthetic Limb Users Survey of Mobility (Plus-M)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Amputee Mobility Predictor (AMP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Independence Measurement-FIM
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Iowa Level of Assistance Scale (ILAS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Walking Speed Scale (IWSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Nano-seq group compared to blood culture group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Specificity of Nano-seq group compared to blood culture group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Level of agreement between Nano-seq group and blood culture group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of participants who decide to enroll
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of OCD patients who remain in clinical trial until completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Self-regulation (youth report)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-regulation (parent report)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Substance use onset
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic ability of thoracic ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective cure evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: feasibility of monitoring for each wearable monitor
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: feasibility of monitoring for the OURA ring and Withings ScanWatch
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: feasibility of monitoring for the Isansys medical devices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: feasibility of monitoring for the daily weights
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Social Emotional Wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Myocardial 123I-MIBG scintigraphy findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cellular immunological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Humoral immunological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse events associated with mechanical ventilation
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage change in scalp hair growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aqueous humor levels of CTGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aqueous humor levels of VEGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic parameters of IBI362
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasopharyngeal colonisation with Neisseria species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA decline of ≥ 30% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: orthodontic plaque index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient saved
Endpoint domain: Mortality/survival
Primary endpoint: Clinical response at week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deep clinical remission at week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucosal healing at week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of impulsivity in addicts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume of prefrontal cortex in addicts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in Wechsler Preschool and Primary Scale of Intelligence, Fourth Edition (WPPSI-IV)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in Child Behavior Checklist (CBCL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total number of bleeding and/or spotting days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of bleeding and/or spotting episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease course prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall patient understanding of Hepatitis D Virus diagnosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IGRT discontinuation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGRT discontinuation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological Major Response (MPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Direct medical expenses
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Direct non-medical expenses
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overhead expenses
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Early diagnosis of pediatric pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in knee kinematics during Single-Leg Squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in knee kinematics during Single-Leg Landing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: VAS Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum IL-6 Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CK Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic Knee Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of Postoperative sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptual speech ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Automated speech analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalized Anxiety Disorder scale (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional status as measured by 6 minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 4-Cardinal Symptom score (4CSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of obstructive CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of MACE
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity and specificity of positive utDNA for urothelial cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement on Neck Disability Index (NDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement on Visual Analogue Scales (VAS arm/neck)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the number of vertigo/migraine days and vertigo/migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vertigo severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in migraine intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Intervention Appropriateness Measure (IAM) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wechsler full-scale intelligence quotient
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Clinical events of safety
Endpoint domain: Adverse events/effects
Primary endpoint: Urine Protein-to-Creatinine Ratio (UPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Range of Motion (ROM) for inversion and eversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Posture Index (FP1-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Dose Limiting Toxicity (DLT) of KB-0742
Endpoint domain: Adverse events/effects
Primary endpoint: Maximally Tolerated Dose (MTD) of KB-0742
Endpoint domain: Adverse events/effects
Primary endpoint: Regained ovarian function based on E2 and FSH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Regained ovarian function based on menstrual bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hours activity behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical activity information
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reactogenicity of the vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: 2D Kinematic Data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate/Severe Persistent Postoperative Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of tissue activated from stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes